Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Invenio Therapeutics Inc
Profile last edited on: 6/25/19      CAGE: 4UCV0      UEI:

Business Identifier: Leukemia therapeutics
Year Founded
2007
First Award
2008
Latest Award
2016
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

11000 Cedar Avenue Suite 100
Cleveland, OH 44106
   (216) 789-6000
   N/A
   www.inveniotherapeutics.com
Location: Single
Congr. District: 11
County: 

Public Profile

Invenio Therapeutics is an early-stage drug discovery company where the intellectual property consists of drug compounds that terminally differentiate leukemia cells so that they no longer have the ability to divide and replicate. Once these cells die, the disease is cured.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
2
Conversion Rate
66.67%
Phase I Dollars
$459,438
Phase II Dollars
$2,486,526
Total Awarded
$2,945,964

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
20-24

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2016 2 NIH $1,682,334
Project Title: Identifying Small Molecule Inhibitors of Hdmx Using Cell-Based Screening
2014 2 NIH $1,129,912
Project Title: Plant-derived differentiation agents for AML
2009 1 NIH $133,718
Project Title: Novel differentiation therapy for AML

Key People / Management

  David Wald -- President

  Mukesh Kumar Agarwal

Company News

Aug 14 2009
Cleveland quietly becoming leader in adult stem cell industry